Partnerships

Global Health Partnership (EDCTP3)

Partnership website: https://www.globalhealth-edctp3.eu/

The partnership aims to deliver new solutions reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities for preparedness and response against reemerging infectious diseases in sub-Saharan Africa and globally. Belgium is member of the EDCTP Association. EDCTP3 was launched in 2022.

The European & Developing Countries Clinical Trials Partnership (EDCTP) exists to accelerate the clinical development of new or improved health technologies for the identification, treatment and prevention of poverty-related and neglected infectious diseases, including (re-)emerging diseases.

The Global Health EDCTP3 Joint Undertaking (Global Health EDCTP3) builds on the first and second EDCTP programmes and is a partnership between the EU and the EDCTP Association, whose members are several European and African countries.

The partnership will deliver new solutions for reducing the burden of infectious diseases in sub-Saharan Africa, and strengthen research capacities to prepare and respond to re-emerging infectious diseases in this region and across the world.

Key figures

Total budget of Global Health EDCTP3 is 1.6 billon euro
The partnership includes 40 European & African countries

Participation Flanders

The following organisations based in Flanders are partner in ongoing EDCTP3 projects (2022 & 2023 work programme):

University of Antwerp in the projects 'SEMA ReACT', 'SNIP-AFRICA', 'GenPath Africa' & 'PROTECT'
Institute for Tropical Medicine (ITM) in the project 'STROGHAT'
Ghent University in the project 'NeuroSolve' & 'ODIN'
Flemish Institute for Biotechnology (VIB) in the project 'ODIN'
Janssen Pharmaceutica nv in the project 'CTCAN'

Past & current calls for proposals

Since it took off in 2022, EDCTP has launched several calls of proposals. Information on the latest calls for proposals can be found in the 2025 annual work programme. Any further information can be found on the EDCTP3 Calls for proposals webpage.

All EDCTP3 calls for proposals are also published on the European Commission’s Funding and Tender opportunities portal.

Key documents

Draft partnership proposal (August 2020)
Strategic Research and Innovation Agenda of the GH EDCTP3 (January 2022)
Policy context: Global health - EDCTP

Contact

Partnership: EC-GLOBAL-HEALTH-EDCTP3@ec.europa.eu

What are partnerships?

Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.

More detailed info Overview of partnerships

How to use partnerships?

orientation
Partnerships publish strategic documents, e.g. outlining the main research and innovation challenges or key focus points.
networking
Partnerships often organise events, such as info days, brokerage events, etc. Meet potential partners and learn about the nuances that are not visible in the official documents.
ecosystem analysis
Partnerships typically have an advisory board, and publish impact studies of previous actions. These are good sources of information to uncover the main R&D&I players in the domain.
steering the agenda
Partnerships collaborate with the EC on outlining the strategy and the future funding opportunities in their domain, based on input from industry, academia, and other stakeholders.

Testimonial

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities.

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.

Read the full article or Check out the other testimonials

Funding programmes

Content

Tools